$ cat ./records/gates-foundation-commits-40-million-challenge-grant-to-carter-cen-2008.txt
Gates Foundation Commits $40 Million Challenge Grant to Carter Center Guinea Worm Eradication Program
[RECORD.TXT] · cat --full
On December 5, 2008, the Gates Foundation announced a $40 million challenge grant — the largest in Carter Center history — comprising an $8 million outright gift and a 1:1 matching grant of up to $32 million for the Guinea Worm Eradication Program. At the time, fewer than 5,000 cases remained globally. The grant accelerated surveillance, water treatment, and case containment; only 13 human cases were reported worldwide in 2022 — down from 3.5 million in 1986 — making Guinea worm the first parasitic disease on the verge of eradication without a vaccine or medicine.
Source: https://www.cartercenter.org/news/pr/gates_120508.html
Free forever · No ads · Solo developer
If this was worth a read, help make the next entry possible.
Every entry in this archive was researched, verified, and written by one person — for free. No corporate funding. No ad revenue. Just a developer who believes verified history should be accessible to everyone. Your donation directly funds new entries.
Crypto accepted · No subscription required
← Previous
Gates Foundation and Buffett Foundation Jointly Fund $47 Million WEMA Partnership for GM Drought-Tolerant Maize in Africa
Next →
Gates Foundation Establishes Institute for Disease Modeling with Open-Source EMOD Epidemic Simulation Platform
[CROSS_REFERENCES] · grep --category='Global Health'
Related Accomplishments
January 2026
Gates-backed World Mosquito Program reaches 16 million people protected from dengue via Wolbachia method
The World Mosquito Program — backed in part by the Gates Foundation — announced in January 2026 that its Wolbachia-infected mosquito releases had reached over 16.1 million people across multiple countries, including Colombia, Indonesia, Brazil, Sri Lanka, Fiji, Vanuatu, and Vietnam. Wolbachia-carrying Aedes aegypti mosquitoes — which block dengue, Zika, chikungunya, and yellow fever transmission — had established self-sustaining populations in treated cities without requiring ongoing releases. Gold-standard randomised trials in Indonesia showed a 77% reduction in dengue incidence. The program represented one of the largest and most cost-effective vector control deployments in history.
2025
Gates-Funded Monoclonal Antibody Shows Early Promise as a Single-Shot Malaria Shield
[ARCHIVE_FUNDING] · INDEPENDENT · NO ADS
One developer. >300 verified entries. Zero ads. Forever free.
No sponsors, no paywall, no algorithm. If this archive has been useful to you, reader support is what keeps it running.